For this, we used three different antibodies, of which two detect polyGln and are commercially available (1C2 and #1874), and one custom antibody, α-DM1, directed against the C-terminus of a predicted glutamine frame of DM1 in the CAG direction (generously provided by Laura Ranum). Here, DMPK is linked to myotonic dystrophy type 1.